NeutralLOW severityHealthcare & Pharma12h ago

Regional Management director Sandra Johnson sells $104,144 in stock

Wook of Wall Street Markets desk analysis

Based on reporting by Investing.com (investing.com) · November 7, 2026 · 2 min read

Regional Management director Sandra Johnson sells $104,144 in stock — $JNJ one-month chart — $JNJ daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

$JNJ today+1.43%last $276.22
52-week range2.1% below high$185.12 – $282.02
In the headline$104,144Amount
Coverage3 this week21 in 30 days · about its usual pace
Next upIn 80 days$JNJ earnings
Sector scannerCalmHealth Care

WOOK’s read

Johnson & Johnson (JNJ) last traded at $276.22, up 1.43%, nearing its 52-week high of $282.02. With 21 stories mentioning the company in the past month—3 in the last week—the coverage has leaned bullish but at a steady pace. The Health Care sector remains calm, and earnings are set for 80 days from now.

Written by Wook AI Nov 7, 12:36 AM ET from this page’s own figures at that time — not from the article — with every number checked against them. Not investment advice.

WOOK AIASK ANYTHING · NEVER ADVISES

Ask about JNJ. Get explanations, comparisons and calculations with the source lookups shown.

Wook analysis

What it means

Key points

What to watch: There is a hard number in this story ($104,144) — the interesting part is how it compares with the last few like it.
How the stock is trading: $JNJ +1.43% in the latest session.
Timing: Weekend news: the change beside it is Friday's, and Monday's open is the first session that gets a say. Market holidays are not detected.

Amount$104,144

Where the stock stands

$JNJ last changed hands at $276.22, +1.43% on the session, 2.1% below its 52-week high of $282.02 and 49% above its low of $185.12 — within a tenth of its 52-week high. Over the year it has ranged 52% from low to high: a wide band, so a several-percent week is just a week. These are latest-session quotes, not live prices — the live tape is on the $JNJ page.

How much coverage it is getting

In the last 30 days Wook has filed 21 stories about $JNJ — 3 of them this week. At its 30-day pace you would expect about 5 a week, so this week is quieter than usual. Across those stories the wording ran 33% bullish, 53% neutral and 14% bearish. This one reads neutral, so it sits squarely with the crowd. 3 came from Investing.com; the rest came from other outlets, so this is a story more than one newsroom is chasing. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.

The bigger picture

Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.

Coming up

$JNJ earnings in 80 days. These were on the calendar before this story and are not caused by it.

What to watch next

For the receipts, the $JNJ page has the full chart, the filings and the valuation model these figures come from. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. Wook AI, above, can pull live figures and run the numbers on request — how far $JNJ is from its high, or how this week's coverage compares.

Discussion

No one has weighed in yet. Start the discussion on this story.

Headline and link are attributed to Investing.com. Wook of Wall Street is an independent research tool and is not affiliated with Investing.com. Nothing here is financial advice or a recommendation — research and educational content only.